Print

Pluristem Therapeutics (PSTI) Issues Letter to Shareholders Highlighting Significant Achievements on Several Fronts  
10/9/2012 9:30:33 AM

HAIFA, Israel, Oct. 9, 2012 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, today announced that the Company has issued a letter to shareholders that provides an overview of the numerous milestones recently achieved by the company. The letter can be found on the company's website. Highlights include:
//-->